Survival analysis based on online databases revealed that KAT6A was markedly, highly expressed in RCC, cholangiocarcinoma, and head and neck squamous cell carcinoma, which was associated with a favorable overall survival (OS) [34]. This evidence concerns the gene KAT6A and renal cell carcinoma.